The results demonstrated that either shRNA knocked down endogenous STAT3 by >60% (Figure 1b) and selectively reduced cell viability of cultured ABC DLBCL as compared with GCB DLBCL cells (Figure 1c). Here, STAT3 is linked to diffuse large B-cell lymphoma.